320 related articles for article (PubMed ID: 8573423)
1. Efficacy and safety of drugs for Paget's disease of bone.
Reginster JY; Lecart MP
Bone; 1995 Nov; 17(5 Suppl):485S-488S. PubMed ID: 8573423
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates for Paget's disease of bone in adults.
Corral-Gudino L; Tan AJ; Del Pino-Montes J; Ralston SH
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD004956. PubMed ID: 29192423
[TBL] [Abstract][Full Text] [Related]
3. A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone.
Walsh JP; Ward LC; Stewart GO; Will RK; Criddle RA; Prince RL; Stuckey BG; Dhaliwal SS; Bhagat CI; Retallack RW; Kent GN; Drury PJ; Vasikaran S; Gutteridge DH
Bone; 2004 Apr; 34(4):747-54. PubMed ID: 15050907
[TBL] [Abstract][Full Text] [Related]
4. Pamidronate is effective for Paget's disease of bone refractory to conventional therapy.
Wimalawansa SJ; Gunasekera RD
Calcif Tissue Int; 1993 Oct; 53(4):237-41. PubMed ID: 8275351
[TBL] [Abstract][Full Text] [Related]
5. [Calcitonin nasal spray for Paget's disease of the bone].
Luboshitzky R; Bar-Shalom R
Harefuah; 1995 Mar; 128(6):358-62, 399. PubMed ID: 7750816
[TBL] [Abstract][Full Text] [Related]
6. Consensus statement on the modern therapy of Paget's disease of bone from a Western Osteoporosis Alliance symposium. Biannual Foothills Meeting on Osteoporosis, Calgary, Alberta, Canada, September 9-10, 2000.
Drake WM; Kendler DL; Brown JP
Clin Ther; 2001 Apr; 23(4):620-6. PubMed ID: 11354395
[TBL] [Abstract][Full Text] [Related]
7. Risedronate: a new oral bisphosphonate.
Umland EM; Boyce EG
Clin Ther; 2001 Sep; 23(9):1409-21. PubMed ID: 11589256
[TBL] [Abstract][Full Text] [Related]
8. Management of Paget's disease of bone.
Langston AL; Ralston SH
Rheumatology (Oxford); 2004 Aug; 43(8):955-9. PubMed ID: 15187244
[TBL] [Abstract][Full Text] [Related]
9. Tiludronate. A new treatment for an old ailment: Paget's disease of bone.
Morales-Piga A
Expert Opin Pharmacother; 1999 Nov; 1(1):157-70. PubMed ID: 11249559
[TBL] [Abstract][Full Text] [Related]
10. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
Abelson A
Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
[TBL] [Abstract][Full Text] [Related]
11. Medical management of Paget's disease of bone: indications for treatment and review of current therapies.
Siris ES; Lyles KW; Singer FR; Meunier PJ
J Bone Miner Res; 2006 Dec; 21 Suppl 2():P94-8. PubMed ID: 17229018
[TBL] [Abstract][Full Text] [Related]
12. The methodology of clinical trials of oral tiludronate in Paget's disease of bone.
Roux C
Bone; 1995 Nov; 17(5 Suppl):497S-499S. PubMed ID: 8573426
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the efficacy and safety of oral tiludronate in Paget's disease of bone. A double-blind, multiple-dosage, placebo-controlled study.
Reginster JY; Colson F; Morlock G; Combe B; Ethgen D; Geusens P
Arthritis Rheum; 1992 Aug; 35(8):967-74. PubMed ID: 1642662
[TBL] [Abstract][Full Text] [Related]
14. Effective oral treatment of severe Paget's disease of bone with APD (3-amino-1-hydroxypropylidene-1,1-bisphosphonate); a comparison with combined calcitonin + EHDP (1-hydroxyethylidene-1,1-bisphosphonate).
Fraser TR; Ibbertson HK; Holdaway IM; Rutland M; King A; Dodd G; Wattie DJ
Aust N Z J Med; 1984 Dec; 14(6):811-8. PubMed ID: 6442563
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic strategy in Paget's disease of bone.
Meunier PJ; Vignot E
Bone; 1995 Nov; 17(5 Suppl):489S-491S. PubMed ID: 8573424
[TBL] [Abstract][Full Text] [Related]
16. Paget's disease of bone: diagnosis and treatment update.
Noor M; Shoback D
Curr Rheumatol Rep; 2000 Feb; 2(1):67-73. PubMed ID: 11123042
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Paget's disease of bone with a combination of intranasal salmon calcitonin and oral calcium and thiazide.
Evans RA; Somers NM; Dunstan CR; Hills E; Evans M
Calcif Tissue Int; 1991 Sep; 49(3):164-7. PubMed ID: 1933580
[TBL] [Abstract][Full Text] [Related]
18. Salmon-calcitonin nasal spray in Paget's disease of bone: preliminary results in five patients.
Reginster JY; Albert A; Franchimont P
Calcif Tissue Int; 1985 Dec; 37(6):577-80. PubMed ID: 3937575
[TBL] [Abstract][Full Text] [Related]
19. Paget's disease of bone. An update on management.
Hosking DJ
Drugs; 1985 Aug; 30(2):156-73. PubMed ID: 3928323
[TBL] [Abstract][Full Text] [Related]
20. Pamidronate sodium and calcitonin-resistant Paget's disease. Immediate response in a patient.
Drake S; Massie JD; Postlethwaite AE; Palmieri GM
Arch Intern Med; 1989 Feb; 149(2):401-3. PubMed ID: 2783843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
